Company profile
Immunobiology Limited
403 Forbidden
Immunobiology Limited is a UK company with status active founded in 1999 based in East of England.
Corporate ownership
Updated 06 Jun 2026 16:52
Latest accounts
Financial period: 1 Jun 2023 to 31 May 2024
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Low cost, broadly efficacious Pneumococcal vaccine
1 Apr 2013 to 31 Mar 2014
Immunisation programmes have proven successful against some of the world’s most deadly diseases but unfortunately vaccines are not available to protect against many existing infections and new vaccine approaches are required urgently to prevent evolving and emerging diseases. For example, vaccines are not available to protect against some strains of bacte...
Market viability of ImmBioVax vaccines against H. Pylori and C. Difficile
1 Mar 2013 to 30 Sep 2013
Vaccines are not yet available to protect against H. Pylori and C. Difficile and the existing therapeutic options available have significant limitations and challenges. Although quoted as significant, the market size for vaccines against these pathogens are poorly defined and the characteristics of a successful prophylactic vaccine product (e.g. productio...
Development of a Universal Meningococcal Vaccine
1 Dec 2012 to 31 May 2014
Vaccine immunisation programmes have proven successful against some of the world’s most deadly diseases, eradicating smallpox and on the edge of eradicating Polio. Unfortunately, vaccines are not available to protect against many existing infections and new vaccine approaches are required to stop evolving and emerging diseases. For example, while vaccines...
Manufacture of Low Cost High Efficacy Vaccine
1 Oct 2009 to 30 Sep 2011
Awaiting Public Summary
Biomanufacture of HspC Vaccines Against Bacterial Pathogens
1 Sep 2007 to 31 Aug 2009
Awaiting Public Summary